9
total announcements
524494.BO · 15 min delayed
Ipca Laboratories Ltd
Ipca Laboratories Ltd reported Q1 FY27 earnings with domestic formulation business growing 13% to INR1,082 crores, export business growing 34% to INR603 crores, and overall business growing 21% to INR2,788 crores. EBITDA margins improved to 22.88% for Q1 FY27 from 18.39% for Q1 FY26.
Ipca Laboratories Ltd
Ipca Laboratories Ltd announced the audio link of its conference call held on August 14, 2026, to discuss Q1FY27 earnings and business update.
Ipca Laboratories Ltd
Ipca Laboratories Ltd and its subsidiary, Solid Stone Company Ltd, have announced their unaudited financial results for the quarter ended June 30, 2026. Ipca Laboratories reported a net profit of Rs. 4.08 lakhs, while its subsidiary Solid Stone Company reported a net loss of Rs. 69.31 lakhs. The results were published in newspapers and filed with the stock exchange.
Ipca Laboratories Ltd
Ipca Laboratories Ltd has announced the voting results and scrutinizer report for its 76th Annual General Meeting held on August 13, 2026. All resolutions placed before the shareholders were passed by requisite majority. The company also declared a dividend on the equity shares.
Ipca Laboratories Ltd
Ipca Laboratories Ltd has announced its unaudited financial results for Q1FY27, with revenue from operations at ₹2,119.24 crore and profit for the period from continuing operations at ₹373.29 crore.
Ipca Laboratories Ltd
Ipca Laboratories Ltd has announced its unaudited financial results for Q1FY27, with revenue from operations at ₹2,119.24 crore and profit for the period from continuing operations at ₹373.29 crore. The company has also disclosed the impact of new Labour Codes, which has resulted in an increase in gratuity and leave liability of ₹30.42 crore.
Ipca Laboratories Ltd
Ipca Laboratories Ltd will host a conference call on August 14th to discuss Q1FY27 earnings and business update.
Ipca Laboratories Ltd
Ipca Laboratories Ltd has scheduled a Board Meeting on 13/08/2026 to consider and approve standalone and consolidated unaudited financial results for the 1st quarter ended 30th June, 2026.
Ipca Laboratories Ltd
Ipca Laboratories Ltd has announced the closure of its trading window for insiders, effective from July 1, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the declaration of the company's unaudited financial results for the first quarter ended June 30, 2026. The trading window will remain closed until 48 hours after the results are publicly disclosed.